Patient-oriented research can be meaningful for clinicians and trialists as well as patients.

Szczegóły
Abstrakt

Tytuł:: Patient-oriented research can be meaningful for clinicians and trialists as well as patients.
Autorzy:: Field TS; Stroke neurologist, associate professor, Vancouver Stroke Program, University of British Columbia, Vancouver, BC.
Dizonno V; Study manager, Vancouver Stroke Program, University of British Columbia, Vancouver, BC.
Park SS; Research assistant, Vancouver Stroke Program, University of British Columbia, Vancouver, BC.
Hill MD; Stroke neurologist, professor, Hotchkiss Brain Institute, Cumming School of Medicine, University of Calgary, Calgary, Alta.
Źródło:: CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne [CMAJ] 2020 Jan 27; Vol. 192 (4), pp. E100.
Typ publikacji:: Letter
Język:: English
Imprint Name(s):: Publication: Ottawa : Canadian Medical Association
Original Publication: [Ottawa] : The Association = L'Association, [1985]-
MeSH Terms:: Patient Participation*
Research Design*
Biomedical Research/*organization & administration
References:: Stroke. 2004 Mar;35(3):664-70. (PMID: 14976332)
J Neurol. 2016 Mar;263(3):477-84. (PMID: 26725090)
CMAJ. 2019 Aug 6;191(31):E860-E864. (PMID: 31387956)
Entry Date(s):: Date Created: 20200129 Date Completed: 20200131 Latest Revision: 20200205
Update Code:: 20240105
PubMed Central ID:: PMC6989020
DOI:: 10.1503/cmaj.74072
PMID:: 31988157
: Opinia redakcyjna

Full Text Finder

Competing Interests: Competing interests: Thalia Field is the principal investigator and Michael Hill is the co-principal investigator of the Study of rivaroxaban in CeREbral venous Thrombosis — SECRET trial. Bayer Canada provided in-kind study medication. No other competing interests were declared.

Informacja